To include your compound in the COVID-19 Resource Center, submit it here.

Unity raises $55M series C

Unity Biotechnology Inc. (San Francisco, Calif.) raised $55 million in a series C round. New

Read the full 159 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE